Oct 21 (Reuters) -
* OPERATION WARP SPEED CHIEF SLAOUI EXPECTS U.S. TRIALS OF VACCINES MADE BY ASTRAZENECA AND JOHNSON & JOHNSON TO RESUME AS SOON AS THIS WEEK-BLOOMBERG Source text : https://bloom.bg/3dOr9RT Further company coverage:
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,050 GBX | -0.87% | +0.52% | +13.68% |
05-03 | Angle shares up on assay development deal with AstraZeneca | AN |
05-03 | Angle shares up on assay development deal with AstraZenaca | AN |
Oct 21 (Reuters) -
* OPERATION WARP SPEED CHIEF SLAOUI EXPECTS U.S. TRIALS OF VACCINES MADE BY ASTRAZENECA AND JOHNSON & JOHNSON TO RESUME AS SOON AS THIS WEEK-BLOOMBERG Source text : https://bloom.bg/3dOr9RT Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+13.68% | 234B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B | |
+1.72% | 123B |